Tuulia Malén , Severi Santavirta , Sven De Maeyer , Jouni Tuisku , Valtteri Kaasinen , Tuomas Kankare , Janne Isojärvi , Juha Rinne , Jarmo Hietala , Pirjo Nuutila , Lauri Nummenmaa
{"title":"神经精神疾病中 2 型多巴胺受体的变化:大规模正电子发射计算机队列","authors":"Tuulia Malén , Severi Santavirta , Sven De Maeyer , Jouni Tuisku , Valtteri Kaasinen , Tuomas Kankare , Janne Isojärvi , Juha Rinne , Jarmo Hietala , Pirjo Nuutila , Lauri Nummenmaa","doi":"10.1016/j.nicl.2024.103578","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>Aberrant dopaminergic function is linked with motor, psychotic, and affective symptoms, but studies have typically compared a single patient group with healthy controls.</p></div><div><h3>Methods</h3><p>Here, we investigated the variation in striatal (caudate nucleus, nucleus accumbens, and putamen) and thalamic type 2 dopamine receptor (D<sub>2</sub>R) availability using [<sup>11</sup>C]raclopride positron emission tomography (PET) data from a large sample of 437 humans including healthy controls, and subjects with Parkinson’s disease (PD), antipsychotic-naïve schizophrenia, severe violent behavior, pathological gambling, depression, and overweight. We analyzed regional group differences in D<sub>2</sub>R availability. We also analyzed the interregional correlation in D<sub>2</sub>R availability within each group.</p></div><div><h3>Results</h3><p>Subjects with PD showed the clearest decline in D<sub>2</sub>R availability. Overall, the groups showed high interregional correlation in D<sub>2</sub>R availability, while this pattern was weaker in violent offenders. Subjects with schizophrenia, pathological gambling, depression, or overweight did not show clear changes in either the regional receptor availability or the interregional correlation.</p></div><div><h3>Conclusion</h3><p>We conclude that the dopaminergic changes in neuropsychiatric conditions might not only affect the overall receptor availability but also how coupled regions are across people. The region-specific receptor availability more profoundly links to the motor symptoms, while the between-region coupling might be disrupted in violence.</p></div>","PeriodicalId":54359,"journal":{"name":"Neuroimage-Clinical","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213158224000172/pdfft?md5=f191098ae02f10dff90773ddf0488128&pid=1-s2.0-S2213158224000172-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Alterations in type 2 dopamine receptors across neuropsychiatric conditions: A large-scale PET cohort\",\"authors\":\"Tuulia Malén , Severi Santavirta , Sven De Maeyer , Jouni Tuisku , Valtteri Kaasinen , Tuomas Kankare , Janne Isojärvi , Juha Rinne , Jarmo Hietala , Pirjo Nuutila , Lauri Nummenmaa\",\"doi\":\"10.1016/j.nicl.2024.103578\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><p>Aberrant dopaminergic function is linked with motor, psychotic, and affective symptoms, but studies have typically compared a single patient group with healthy controls.</p></div><div><h3>Methods</h3><p>Here, we investigated the variation in striatal (caudate nucleus, nucleus accumbens, and putamen) and thalamic type 2 dopamine receptor (D<sub>2</sub>R) availability using [<sup>11</sup>C]raclopride positron emission tomography (PET) data from a large sample of 437 humans including healthy controls, and subjects with Parkinson’s disease (PD), antipsychotic-naïve schizophrenia, severe violent behavior, pathological gambling, depression, and overweight. We analyzed regional group differences in D<sub>2</sub>R availability. We also analyzed the interregional correlation in D<sub>2</sub>R availability within each group.</p></div><div><h3>Results</h3><p>Subjects with PD showed the clearest decline in D<sub>2</sub>R availability. Overall, the groups showed high interregional correlation in D<sub>2</sub>R availability, while this pattern was weaker in violent offenders. Subjects with schizophrenia, pathological gambling, depression, or overweight did not show clear changes in either the regional receptor availability or the interregional correlation.</p></div><div><h3>Conclusion</h3><p>We conclude that the dopaminergic changes in neuropsychiatric conditions might not only affect the overall receptor availability but also how coupled regions are across people. The region-specific receptor availability more profoundly links to the motor symptoms, while the between-region coupling might be disrupted in violence.</p></div>\",\"PeriodicalId\":54359,\"journal\":{\"name\":\"Neuroimage-Clinical\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2213158224000172/pdfft?md5=f191098ae02f10dff90773ddf0488128&pid=1-s2.0-S2213158224000172-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuroimage-Clinical\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2213158224000172\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"NEUROIMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroimage-Clinical","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213158224000172","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROIMAGING","Score":null,"Total":0}
Alterations in type 2 dopamine receptors across neuropsychiatric conditions: A large-scale PET cohort
Purpose
Aberrant dopaminergic function is linked with motor, psychotic, and affective symptoms, but studies have typically compared a single patient group with healthy controls.
Methods
Here, we investigated the variation in striatal (caudate nucleus, nucleus accumbens, and putamen) and thalamic type 2 dopamine receptor (D2R) availability using [11C]raclopride positron emission tomography (PET) data from a large sample of 437 humans including healthy controls, and subjects with Parkinson’s disease (PD), antipsychotic-naïve schizophrenia, severe violent behavior, pathological gambling, depression, and overweight. We analyzed regional group differences in D2R availability. We also analyzed the interregional correlation in D2R availability within each group.
Results
Subjects with PD showed the clearest decline in D2R availability. Overall, the groups showed high interregional correlation in D2R availability, while this pattern was weaker in violent offenders. Subjects with schizophrenia, pathological gambling, depression, or overweight did not show clear changes in either the regional receptor availability or the interregional correlation.
Conclusion
We conclude that the dopaminergic changes in neuropsychiatric conditions might not only affect the overall receptor availability but also how coupled regions are across people. The region-specific receptor availability more profoundly links to the motor symptoms, while the between-region coupling might be disrupted in violence.
期刊介绍:
NeuroImage: Clinical, a journal of diseases, disorders and syndromes involving the Nervous System, provides a vehicle for communicating important advances in the study of abnormal structure-function relationships of the human nervous system based on imaging.
The focus of NeuroImage: Clinical is on defining changes to the brain associated with primary neurologic and psychiatric diseases and disorders of the nervous system as well as behavioral syndromes and developmental conditions. The main criterion for judging papers is the extent of scientific advancement in the understanding of the pathophysiologic mechanisms of diseases and disorders, in identification of functional models that link clinical signs and symptoms with brain function and in the creation of image based tools applicable to a broad range of clinical needs including diagnosis, monitoring and tracking of illness, predicting therapeutic response and development of new treatments. Papers dealing with structure and function in animal models will also be considered if they reveal mechanisms that can be readily translated to human conditions.